{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-006220","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2023-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.031885+00:00","generated_at":"2026-06-15T04:20:12.454976+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Zomedica Q1 revenue up 45% to $5.5M; net loss widens to $6.4M","bullets":["Revenue $5.5M (+45% YoY); gross margin 70%; net loss $6.4M ($0.007/share) vs $3.9M loss a year ago.","Diagnostic segment revenue $0.4M (+300% YoY); Therapeutic segment $5.1M (+38% YoY).","Cash and securities $147.5M; cash used in Q1 was $8.3M including $4.0M TRUFORMA licensing fees.","Paid $250k non-refundable deposit to exercise acquisition option for Structured Monitoring Products (VetGuardian).","Amended Georgia lease to add 6,000 sq ft for TRUFORMA cartridge manufacturing; TRUVIEW digital microscopy system launch planned in Q2."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-006220","json":"https://secwatch.observer/filing/0001654954-23-006220.json","markdown":"https://secwatch.observer/filing/0001654954-23-006220.md","text":"https://secwatch.observer/filing/0001654954-23-006220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000165495423006220/0001654954-23-006220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000165495423006220/zom_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T04:20:12.454976+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e36bdb06a31b9796e02a0aaebc16d72846ae462","claim":"Zomedica Corp. reported three months ended March 31, 2023 results: revenue $5.5 million.","evidence_excerpt":"Revenue for the first quarter of 2023 was $5.5 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1684144/000165495423006220/0001654954-23-006220-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2023"},{"label":"Revenue","value":"$5.5 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}